​Following reports on Friday that an agreement had been reached between FC Barcelona and Borussia Dortmund for Karim Adeyemi, a medical examination has now been scheduled for the 24-year-old striker. As per transfer insider Gianluca Di Marzio, Adeyemi is slated to undergo his medical on Wednesday, with the formal confirmation of the deal anticipated to follow on Thursday. The development marks a pivotal moment in this high-profile transfer, signaling that negotiations have advanced beyond negotiations and into the final stages of medical clearance before an official unveiling.
The forthcoming medical is a crucial step in solidifying the transfer, and it is expected to pave the way for Barcelona to officially announce the acquisition in the near future. Once the medical is completed successfully, the clubs are poised to make a joint public statement detailing the terms of the agreement, the timeline for the player’s integration, and any conditional clauses attached to the deal. The football world has been watching closely, given Adeyemi’s potential impact and the strategic implications for both clubs.
From a financial perspective, Dortmund is projected to receive a guaranteed transfer fee of €22 million for Adeyemi. This baseline could increase by up to €7 million, contingent on a series of performance-related bonuses that reflect the player’s contributions on the pitch and the achievement of specific targets over the course of his contract. Such add-ons are a common feature in modern football transfers, providing a mechanism for the selling club to benefit from the player’s future success and ensuring alignment of incentives between the player, the buying club, and the seller.
In addition to the guaranteed fee and potential bonuses, Dortmund is reported to have secured a 35 percent sell-on clause in the deal. This arrangement means that if Barcelona later sells Adeyemi to another club, Dortmund would receive 35 percent of any subsequent transfer fee, a provision that offers Dortmund a continuing financial incentive from the player’s career trajectory even after the handover. Sell-on clauses of this nature are frequently negotiated to reward the selling club for its role in the player’s development and to maintain a lasting economic link between the clubs as Adeyemi’s career progresses.
Adeyemi’s move would represent a meaningful shift in the tactical landscape for both clubs. For Barcelona, acquiring a young, versatile forward who can contribute in multiple attacking roles could bolster depth and competition within the squad, potentially offering fresh options in front of goal and extending the club’s attacking repertoire. For Dortmund, the sale would provide a substantial immediate fee and the opportunity to reinvest in new talent or other strategic areas of the squad, while still monitoring the player’s onward career through the sell-on provision.
As the medical date approaches, fans and analysts will be keen to see how Adeyemi’s style of play, leadership on the field, and adaptability to a new league and system align with Barcelona’s tactical philosophy. The transfer process, now entering its final phase, underscores the global nature of the transfer market and the careful negotiation required to balance player ambitions, club strategies, and financial considerations.
In summary, the latest updates indicate that Adeyemi’s medical is scheduled for Wednesday, with an official deal announcement expected the following day. The deal reportedly guarantees Dortmund €22 million, with potential adds of up to €7 million based on performance, and includes a 35 percent sell-on clause for Dortmund, reflecting both the financial and strategic implications of this high-profile transfer. Once medical clearance is achieved and the official statement is released, the football world will have a clearer understanding of how Adeyemi will fit into Barcelona’s plans and what this move means for both clubs’ futures.